[Contrast media in magnetic resonance tomography. A review. 2. Biological basis, research technic and clinical application of gadolinium-DTPA in the diagnosis of intracranial tumors].
The early results of the use of the MR specific contrast medium gadolinium-DTPA in 40 patients with intracranial tumours are reported. Optimal pulse sequences, contrast dose and timing are discussed. The relationship between the blood-brain barrier and contrast distribution within tumour tissue is elaborated. The clinical significance of the application of contrast agents in the diagnosis of brain tumours is evaluated.